U2AF1 mutations alter splice site recognition in hematological malignancies

Genome Research

Volumn 25, Issue 1, 2015, Pages 14-26

  Ilagan, Janine O ^a   Ramakrishnan, Aravind ^a,b   Hayes, Brian ^a   Murphy, Michele E ^a   Zebari, Ahmad S ^a   Bradley, Philip ^a   Bradley, Robert K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; DNA METHYLTRANSFERASE 3B; FANCONI ANEMIA GROUP A PROTEIN; U2AF1 PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ATM PROTEIN; ATR PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; DNA (CYTOSINE 5) METHYLTRANSFERASE; FANCA PROTEIN, HUMAN; H2AFY2 PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; RIBONUCLEOPROTEIN; RNA SPLICING; U2AF1 PROTEIN, HUMAN;

ALLELE; ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; EXON SKIPPING; GENE EXPRESSION; GENE MUTATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; X CHROMOSOME INACTIVATION; ZINC FINGER MOTIF; CHEMICAL STRUCTURE; GENETICS; HEMATOLOGIC DISEASE; K562 CELL LINE; METABOLISM; MUTATION; PATHOLOGY; RNA SPLICING;

APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CASPASE 8; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA DAMAGE; DNA METHYLATION; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; HEMATOLOGIC NEOPLASMS; HISTONES; HUMANS; K562 CELLS; MODELS, MOLECULAR; MUTATION; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS; RNA SPLICE SITES; RNA SPLICING; ZINC FINGERS;

EID: 84920688391     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.181016.114     Document Type: Article

References (48)

1. Bradley RK, Merkin J, Lambert NJ, Burge CB. 2012. Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution. PLoS Biol 10: E1001229.
2. Brooks AN, Choi PS, de Waal L, Sharifnia T, Imielinski M, Saksena G, Pedamallu CS, Sivachenko A, Rosenberg M, Chmielecki J, et al. 2014. A pan-cancer analys is of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. PLoS ONE 9: E87361.
3. The Cancer Genome Atlas Research Network. 2013. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368: 2059-2074.
4. Cvitkovic I, Jurica MS. 2012. Spliceosome Database: A tool for tracking components of the spliceosome. Nucleic Acids Res 41: D132-D141.
5. Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, et al. 2013. Ensembl 2013. Nucleic Acids Res 41: D48-D55.
6. Folc o EG, Lei H, Hsu JL, Reed R. 2012. Small-scale nuclear extracts for functional assays of gene-expression machineries. J Vis Exp 64: E4140.
7. Gelsi-Boyer V, Trouplin V, Ad-elä?de J, Bonansea J, Cerve ra N, Carbuccia N, Lagarde A, Pr-ebet T, Nezri M, Sainty D, et al. 2009. Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol 145: 788-800.
8. Gentlem an RC, Carey VJ, Bates DM, Bolstad B, DettlingM, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5: R80.
9. Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J, Krysiak K, Harris CC, Koboldt DC, Larson DE, et al. 2011. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 44: 53-57.
10. Guth S, Tange T∅ , Kellenberger E, Valc-arcel J. 2001. Dual function for U2AF35 in AG-dependent pre-mRNA splicing. Mol Cell Biol 21: 7673-7681.
11. Harbour JW, Roberson EDO, Anbunathan H, Onken MD, Worley LA, Bowcock AM. 2013. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45: 133-135.
12. Hern-andez-Munoz I, Lund AH, van der Stoop P, Boutsma E, Muijrers I, Verhoeven E, Nusinow DA, Panning B, Marahrens Y, van Lohuizen M. 2005. Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2 A1 and the CULLIN3/SPOP ubiquitin E3 ligase. Proc Natl Acad Sci 102: 7635-7640.
13. Hubert CG, Bradley RK, Ding Y, Toledo CM, Herman J, Skutt-Kakaria K, Girard EJ, Davison J, Berndt J, Corrin P, et al. 2013. Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev 27: 1032-1045.
14. Hudson BP, Martinez-Yamout MA, Dyson HJ,Wright PE. 2004. Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 11: 257-264.
15. Jurica MS, Licklider LJ, Gygi SR, Grigorieff N, Moore MJ. 2002. Purification and charact erization of native spliceosomes suitable for threedimensional structural analysis. RNA 8: 426-439.
16. Katz Y, Wang ET, Airoldi EM, Burge CB. 2010. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 7: 1009-1015.
17. Kielkopf CL Rodionova N.A. Green MR Burley SK. 2001 A novel peptide recognitionmode revealed by the x-ray structure of a coreU2AF35/U2AF65 heterodimer Cell 106 595-605.
18. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
19. Leaver-Fay A, Tyka M, Lewis SM, Lange OF, Thompson J, Jacak R, Kaufman K, Renfrew PD, Smith CA, Sheffler W, et al. 2011. ROSETTA3: An objectoriented software suite for the simulation and design of macromolecules. Methods Enzymol 487: 545-574.
20. Ley TJ, Ding L,Walter MJ, McLellanMD,Lamprecht T, Larson DE, Kandoth C, Payton JE, Baty J,Welch J, et al. 2010. DNMT3A mutations in acute myeloid leu kemia. N Engl J Med 363: 2424-2433.
21. Li B, Dewey CN. 2011. RSEM: Accurate transcript quantification from RNASeq data with or without a reference genome. BMC Bioinformatics 12: 323.
22. M akishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A, Przychodzen B, Bupathi M, Guinta K, Afable MG, et al. 2012. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 119: 3203-3210.
23. Martin M, Maß höfer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch AG, Horsthemke B, et al. 2013. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45: 933-936.
24. Merendino L, Guth S, Bilbao D, Mart-?nez C, Valc-arcel J. 1999. Inhibition of msl-2 splicing by sex-lethal reveals interaction between U2AF35 and the 39 splice site AG. Nature 402: 838-841.
25. Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, Sloan CA, Rosenbl oom KR, Roe G, Rhead B, et al. 2013. The UCSC Genome Browser database: Extensions and updates 2013. Nucleic Acids Res 41: D64-D69.
26. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P , Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, et al. 2011. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365: 1384-1395.
27. Pr zychodzen B, Jerez A, Guinta K, Sekeres MA, Padgett R, Maciejewski JP, Makishima H. 2013. Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms. Blood 122: 999-1006.
28. Quesad a V, Conde L, Villamor N, Ord-onez GR, Jares P, Bassaganyas L, Ramsay AJ, Be-A S, Pinyol M, Mart-?nez-Trillos A, et al. 2011. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52.
29. Reed R. 1989. The organization of 39 splice-site sequences in mammalian introns. Genes Dev 3: 2113-2123.
30. Reichert VL, Le Hir H, Jurica MS, Moore MJ. 2 002. 59 exon interactions within the human spliceosome establish a framework for exon junction complex structure and assembly. Genes Dev 16: 2778-2791.
31. Shen H, Zheng X, Luecke S, Green MR. 2010. The U2AF35-related protein Urp contacts the 39 splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev 24: 2389-2394.
32. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, et al. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15: 1034-1050.
33. Smith CW, Chu TT, Nadal-Ginard B. 1993. Scanning and competition between AGs are involved in 39 splice site selection in mammalian introns. Mol Cell Biol 13: 4939-4952.
34. Taskesen E, Havermans M, van Lom K, Sanders MA, van Norden Y, Bindels E, Hoogenboezem R, Reinders MJT, FigueroaME, Valk PJM, et al. 2014. Two splice factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling. Blood 123: 3327-3335.
35. Tefferi A, Vardiman JW. 2009. Myelodysplastic syndromes. N Engl J Med 361: 1872-1885.
36. Thol F, Kade S, Schlarmann C, Löffeld P, Morgan M, Krauter J, WlodarskiMW, Kölking B,Wichmann M, Görlich K, et al. 2012. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119: 3578-3584.
37. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
38. The UniProt Consortium. 2012. Reorganizing the protein space at the Universal Protein Resource (UniProt) Nucleic Acids Res 40 D71-D75.
39. Visconte V,MakishimaH, Jankowska A, Szpurka H, Tr aina F, Jerez A,O'Keefe C, Rogers HJ, Sekeres MA, Maciejewski JP, et al. 2012. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 26: 542-545.
40. Wagen makers EJ, Lodewyckx T, Kuriyal H, Grasman R. 2010. Bayesian hypothesis testing for psychologists: A tutorial on the Savage-Dickey method. Cognit Psychol 60: 158-189.
41. WalterMJ,Ding L, ShenD, Shao J,Gril lotM,McLellanM, FultonR, Schmidt H, Kalicki-Veizer J, O'Laughlin M, et al. 2011. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25: 1153-1158.
42. Webb CJ, Wise JA. 2004. The splicing factor U2AF small subunit is functionally conserved between fission yeast and humans. Mol Cell Biol 24: 4229-4240.
43. Wong JJL, Ritchie W, Ebner OA, Selbach M, Wong JWH, Huang Y, Gao D, Pinello N, Gonzalez M, Baidya K, et al. 2013. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 154: 583-595.
44. Wu S, Romfo CM, Nilsen TW, Green MR. 1999. Functional recognition of the 39 splice site AG by the splicing factor U2AF35. Nature 402: 832-835.
45. Yildirim E, Kirby JE, Brown DE, Mercier FE, Sadreyev RI, Scadden DT, Lee JT. 2013. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 152: 727-742.
46. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, et al. 2011. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478: 64-69.
47. Young MD, Wakefield MJ, Smyth GK, Oshlack A. 2010. Gene ontology analysis for RNA-seq: Accounting for selection bias. Genome Biol 11: R14.
48. Zorio DA, Blumenthal T. 1999. Both subunits of U2AF recognize the 39 splice site in Caenorhabditis elegans. Nature 402: 835-838.